Expression of XBP1s in B lymphocytes is critical for pristane-induced lupus nephritis in mice
Authors:
- 1 May 2020
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 318 (5) , F1258-F1270
Abstract
B lymphocyte hyperactivity plays a pathogenic role in systemic lupus erythematosus (SLE), and spliced X box-binding protein 1 (XBP1s) has been implicated in B cell maturation and differentiation. We hypothesized that blockade of the XBP1s pathway inhibits the B cell hyperactivity underlying SLE and lupus nephritis (LN) development. In the present study, we systematically evaluated the changes in B cell activation induced by the Xbp1 splicing inhibitor STF083010 in a pristane-induced lupus mouse model. The lupus mouse model was successfully established, as indicated by the presence of LN with markedly increased urine protein levels, renal deposition of Ig, and mesangial cell proliferation. In lupus mice, B cell hyperactivity was confirmed by increased CD40 and B cell-activating factor levels. B cell activation and plasma cell overproduction were determined by increases in CD40-positive and CD138-positive cells in the spleens of lupus mice by flow cytometry and further confirmed by CD45R and Ig light chain staining in the splenic tissues of lupus mice. mRNA and protein expression of XBP1s in B cells was assessed by real-time PCR, Western blot analysis, and immunofluorescence analysis and was increased in lupus mice. In addition, almost all changes were reversed by STF083010 treatment. However, the expression of XBP1s in the kidneys did not change when mice were exposed to pristane and STF083010. Taken together, these findings suggest that expression of XBP1s in B cells plays key roles in SLE and LN development. Blockade of the XBP1s pathway may be a potential strategy for SLE and LN treatment.Keywords
Funding Information
- National Natural Science Foundation of China (81470993, 81272621)
- Baxter International (CHN-RENAL-IIS-2012-039)
- Xijing Hospital Foundation (XJGX15Y45)
This publication has 64 references indexed in Scilit:
- Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myelomaBlood, 2011
- Regulation of unfolded protein response modulator XBP1s by acetylation and deacetylationBiochemical Journal, 2010
- TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophagesNature Immunology, 2010
- Pathogenesis of kidney disease in systemic lupus erythematosusCurrent Opinion in Rheumatology, 2009
- Induction of autoimmunity by pristane and other naturally occurring hydrocarbonsTrends in Immunology, 2009
- Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formationBlood, 2009
- IRE1 Signaling Affects Cell Fate During the Unfolded Protein ResponseScience, 2007
- T Cells and B Cells in Lupus NephritisSeminars in Nephrology, 2007
- B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose‐escalation trial of rituximabArthritis & Rheumatism, 2004
- XBP1 mRNA Is Induced by ATF6 and Spliced by IRE1 in Response to ER Stress to Produce a Highly Active Transcription FactorCell, 2001